BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3554169)

  • 1. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats.
    Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C
    Peptides; 1987; 8(1):89-93. PubMed ID: 3554169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
    Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
    Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of enkephalinase inhibitors on gastric emptying in mice depends on the nature of the meal.
    Liberge M; Rivière PM; Buéno L
    Life Sci; 1988; 42(21):2047-53. PubMed ID: 3164437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
    Rivière PJ; Buéno L
    Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
    Livingston SJ; Sewell RD; Rooney KF; Smith HJ
    Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two opposite effects of clonidine on gastric acid secretion in the dog.
    Soldani G; Del Tacca M; Bernardini C; Martinotti E; Impicciatore M
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):139-42. PubMed ID: 6493358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor.
    Jivegård L; Pollard H; Moreau J; Schwartz JC; Thune A; Svanvik J
    Clin Sci (Lond); 1989 Jul; 77(1):49-54. PubMed ID: 2758762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sauvagine: effects on gastric acid secretion in rats.
    Improta G; Broccardo M
    Peptides; 1988; 9(4):843-6. PubMed ID: 2906430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
    Chipkin RE; Latranyi MB; Iorio LC
    Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for histamine H3 receptor in the control of gastric acid secretion in cats.
    Bado A; Hervatin F; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G631-5. PubMed ID: 1850206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive effects of morphine and of an enkephalinase inhibitor on responses of ventro-basal thalamic neurones to noxious stimuli.
    Guilbaud G; Kayser V; Benoist JM; Gautron M
    Life Sci; 1983; 33 Suppl 1():545-7. PubMed ID: 6363853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin.
    Llorens-Cortes C; Schwartz JC
    Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
    Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
    Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.